Amryt Pharma Share Discussion Threads

[greendragon777] 08/1/2018 12:34

Not bad at all for single country PTGInt. We wouldn't need too many more of these to start hitting a revenue stream of circa €20m-€25m per annum!

[ptgint] 08/1/2018 12:11

Thanks Solomon. Presumably the dose is one-a-day of whatever strength so that would equate to a turnover in Switzerland of circa £3.4 million if all 15 patients were prescribed it. Shows the potential in a larger country.

[greendragon777] 08/1/2018 11:39

How much revenue would that be Paps, €3m perhaps? A few more of those would be nice in Q1! ☺

[solomon] 08/1/2018 11:39

Quite expensive:

5mg orange cap, 28=£17,765.00.
10mg orange/white cap, 28=£17,765.00.
20mg white cap, 28=£17,765.00.

I think I would buy the 20mg pills and cut them into quarters.

[ptgint] 08/1/2018 11:32

Does anyone know what price Lojuxta sells for ?

[papillon] 08/1/2018 10:47

It's not "Very good news", Filterwest. I'd say it's moderately good news. After all there are only 15 possible patients in Switzerland.

"The Company currently estimates that there are approximately 15 patients with HoFH in Switzerland"

[filterwest] 08/1/2018 07:08

Very good news.

[papillon] 05/1/2018 16:40

Current mid price of 19.70p is a complete nonsense. One can buy below that price. Because of that fact all the trades today and yesterday are being shown as sells on the financial web sites, when if fact some have been buys.

I wonder why the MM's persist in quoting a spread of 19.4p - 20p when one can buy below the mid price? I'm afraid the AMYT share price is only going one way in the short term IMO. bwtfdik?

If it does drop back to 18p to fill that "Gap Up" I might be tempted to have a small top up. We'll see what happens.

[papillon] 05/1/2018 14:04

I suspect this has got further to fall in the short term. It wouldn't surprise me to see the share price fall to fill the "Gap Up" back in November. That would mean a fall back to 18p in the short term. bwtfdik?

[papillon] 04/1/2018 12:51

LOL, greendragon.

[greendragon777] 04/1/2018 12:18

Hahaha....exactly Paps. We'll all be "Wide Awake in America" then....including U2! 😂😂😂

[papillon] 04/1/2018 11:16

Message to the AMYT sp; "Wake Me up Before You Go Go". Then Wham!

[greendragon777] 04/1/2018 10:03

It is a snooze fest right now but hopefully we will get well rewarded for these snoozes! 😁

Another Lojuxta type deal would kick the year off nicely! 👍

[alphabravo321] 04/1/2018 08:52

Roll on the interim report on AP 101...bit of a snooze fest at the moment

[papillon] 28/12/2017 23:49

Log chart.


free stock charts from uk.advfn.com

[papillon] 28/12/2017 17:53

Big sell today of 130,752 shares @ 19.55p (below bid price), yet the share price still managed a rise on the day.

[greendragon777] 22/12/2017 17:35

It sure did Paps.....it was a bloodbath for a while but thankfully I was sitting on about 85% cash and managed to convert all of it to IOTAs. I'm really happy with the entry price and it's good to be back in the market but the market will be very jittery for a while after such a tanking.

Up 35% already but my small holding that I had before the crash is still under water about 25%. Good result overall.....this is Cryptoland though so that could change in an instant! 🙈

It's interesting because it was the first crash I've seen that wasn't related to any specific news or developments....just a big correction/crash. The market needed it though, it was insane and still may prove to be way overheated but only time will tell.

[papillon] 22/12/2017 16:48

I see the cryptocurrences are crashing, greendragon. BITCOIN down 19.4% and your favourite, IOTA, is down 44.2%. Has the bubble burst? Looks like it from the charts.

[papillon] 22/12/2017 14:36

I think Jacksonpollack will be disappointed with the new website, dave; no pictures of snouts in the trough! LOL.

I don't know how Jp imagines AMYT will be successful in marketing in the Middle East, North Africa & Eastern Europe if they don't employ a marketing manager with experience in those regions. Unfortunately every pharma company needs to employee marketing people to sell it's products; it would be nice if AMYT didn't have to employ expensive marketing managers, but I doubt they would sell much product! Jp wants to wake up and smell the coffee!

Only time will tell if AMYT becomes another SHP (Mkt Cap £35bn), or another VAL (Mkt Cap (£12m)!! Fingers crossed it's the former! LOL.

[bigwavedave] 21/12/2017 15:55

new website:

[jacksonpollack] 20/12/2017 16:53

More snouts to the trough. Will need another placing soon to keep all the mouths fed.

[papillon] 20/12/2017 14:34

It's shown on the lse site, dave. Very occasionally advfn does miss RNS's. It does look like a good appointment, Punter6, especially with his previous experience in Saudi Arabia, Eastern Europe & North Africa, areas where AMYT obviously wishes to expand into.

[punter6] 20/12/2017 12:20

Good appointment.

[bigwavedave] 20/12/2017 08:35

Amryt Pharma, a biopharmaceutical company focused on treatments for rare and orphan diseases, is pleased to announce the appointment of Patrick Jordan as Vice-President of Global Distributor Markets

Has not been issued by ADVFN, for some reason: